HealthInvest Partners AB - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 56 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2021. The put-call ratio across all filers is 0.62 and the average weighting 1.9%.

Quarter-by-quarter ownership
HealthInvest Partners AB ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$4,035,000
+33.7%
1,265,000
+78.9%
9.30%
+93.5%
Q1 2022$3,019,000
-21.8%
707,000
-14.8%
4.81%
-11.6%
Q4 2021$3,860,000
+258.4%
830,000
+207.4%
5.44%
+237.2%
Q3 2021$1,077,000270,0001.61%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders